SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corp. (NASDAQ: BSDM) today reported that a study titled “Biological Rationales and Clinical Applications of Temperature Controlled Hyperthermia – Implications for Multimodal Cancer Treatments” has been published in Current Medicinal Chemistry (Current Medicinal Chemistry, 2010, 17, 3045-3057). The article, which was authored by leading researchers Schildkopf, Ott, Frey, Wadepohl, Sauer, Fietkau and Gailpl, can be accessed at http://www.bentham.org/cmc/contabs/cmc17-27.htm#5.
